CRBP
CRBP
NASDAQ · Biotechnology

Corbus Pharmaceuticals Holdi

$10.40
-0.09 (-0.86%)
As of Aug 18, 2:25 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +16.8% upside
Low Target $8.71
Average Target $12.15
High Target $17.60
Current Price $10.40
Current
$10.40
Target
$12.15
$8.71 $12.15 avg $17.60
Scenario Analysis
Bear Case
$8.71
-16.3%
Low target
Base Case
$12.15
+16.8%
Avg target
Bull Case
$17.60
+69.2%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$20.56
-49.4% from high
52-Week Low
$7.12
+46.1% from low
Target vs 52W High
$12.15
-40.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -0.5%
AMGN
Amgen Inc
Hold 43 49% $190.87 -55.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +152.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.1%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -47.2%
BIIB
Biogen Inc
Buy 43 67% $91.45 -57.0%